Between 30% to 50% of cancer cases are preventable, according to the World Health Organization. Precluding the advancement of cancer can save patients and payers money and lead to a better quality of life.
Feyi Ayodele, founder and CEO at CancerIQ, sat down with MobiHealthNews to discuss CancerIQ's offerings and how healthcare organizations use its technology to detect and thwart the...
Roche, one of the largest pharma companies in Europe, has been expanding its ambitions in genomic and personalized medicine, emerging practices that use information about a patient's genetic profile or proteins to prevent, diagnose or treat disease.
Dr. Oliver Bleck, area head of Europe South at Roche, joined MobiHealthNews to discuss Roche's advancements in oncology, its current work in...
Astronauts face a myriad of health challenges in space, including exposure to radiation, risk of bone deterioration, vestibular issues and various other concerns.
Space health researchers are continuously looking for ways to prevent and treat medical problems before they arise. Enter precision medicine: an increasingly popular strategy that consider specific variations in a patient’s genetic...
02:29 pm
June 28, 2019
Looking to the personalized medicine space, Blue Shield of California announced yesterday that it is relaunching its wellness platform Wellvolution, angling to give its members options on how to pursue individualized health and wellness goals.
The new technology is born from a collaboration between the insurer and Solera Health, a digital marketplace for benefits and chronic disease management...
Awareness of personalized medicine and treatment is slowly, but gradually, on the rise, according to the results of a recent survey polling 1,000 consumers published by automated dosage platform maker Dosis.
What’s more, older consumers are the most likely demographic to have some awareness of personalized medicine, as well as the first to admit that their prescriptions are not adequately...
23andMe on Wednesday announced that GlaxoSmithKline has invested $300 million to gain exclusive access to the genetic testing startup’s DNA database.
The deal comes as GlaxoSmithKline amid reports that GSK is weighing the possibility of a company breakup and investors contending that synergies between consumer markets and big pharma are inherently limited and that GSK’s pharmaceuticals business...
As digital health, big data, and personalized medicine continue to stake their claim within healthcare, professional associations are starting to take notice. The latest is the American College of Cardiology (ACC), which recently published a policy paper highlighting its outlook on the future of care and technology’s role within it.
“Important within [healthcare’s] transformation are newly...
Veritas Genetics,a leader in whole-genome sequencing, has acquired computing and bio-informatics firm Curoverse for an undisclosed amount. Curoverse provides infrastructure for life sciences companies to manage large datasets, including an open source platform called Arvados.
The acquisition isn't totally unexpected, since the two companies have a strong existing relationship. Not only were both...
Dr. Patrick Soon-Shiong
EHR vendor Allscripts and NantHealth, the digital health wing of Dr. Patrick Soon-Shiong's NantWorks portfolio of companies, have announced a major cross investment, with Allscripts paying $200 million for a stake in NantHealth and Soon Shiong making a $100 million investment in Allscripts via his personal investment vehicle NantCapital.
"We're taking an important step...
Kaiser Permanente CEO Bernard Tyson believes three major trends are driving changes in the healthcare system, he said during his keynote on the final day of the Health 2.0 event in Santa Clara, California. Those include a shift to holistic, lifelong care; the rise of the patient as active healthcare consumer; and the decentralization of healthcare.
"Eventually, as we disrupt the healthcare system...
